COMMUNIQUÉS West-GlobeNewswire

-
Certara to Report First Quarter 2024 Financial Results on May 7th, 2024 and Participate in the BofA Securities Healthcare Conference
09/04/2024 -
AMN Healthcare to Hold First Quarter 2024 Earnings Conference Call on Thursday, May 9, 2024
09/04/2024 -
Oncocyte to Announce Fourth Quarter and Full Year 2024 Financial Results
09/04/2024 -
BrightSpring Health Services, Inc. to Announce First Quarter 2024 Financial Results on May 2, 2024, and Participate in the Bank of America 2024 Healthcare Conference
09/04/2024 -
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
09/04/2024 -
Enliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
09/04/2024 -
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
09/04/2024 -
Rakovina Therapeutics Presented at American Association of Cancer Research Annual Meeting at the San Diego Convention Center Today
09/04/2024 -
NeurAxis Reports Fourth Quarter and Fiscal Year 2023 Financial Results
09/04/2024 -
Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024
09/04/2024 -
Corvus Pharmaceuticals Announces Initiation of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis
09/04/2024 -
Mural Oncology Presents Preclinical Data for IL-18 and IL-12 Programs at the 2024 American Association for Cancer Research Annual Meeting
09/04/2024 -
Olansky Dermatology & Aesthetics welcomes physician assistant, expands hours
09/04/2024 -
Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins
09/04/2024 -
Ultimovacs – Invitation to Business Update on April 17, 2024
09/04/2024 -
Bright Peak Therapeutics Presents New Data at the 2024 American Association for Cancer Research (AACR) Annual Meeting
09/04/2024 -
AssureCare Celebrates Parth Shah's Recognition as a Leader in Healthcare Innovation
09/04/2024 -
Nurix Therapeutics Reports First Clinical Evidence of CNS Activity of NX-5948, a Brain-Penetrant, Orally Available, BTK Degrader in Development for B Cell Malignancies
09/04/2024 -
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet
09/04/2024
Pages